Summary
Othman Guenoun
Business Developer
Technology
- Immunohistochemistry detects cancer cells by applying a solution of fluorescent antibodies to biopsied tissue. After washing and observation under a microscope, the fluorescence reveals the presence of cancer cells, enabling an accurate diagnosis.
- Our invention drastically reduces the time required for interactions between antibodies and antigens to take place: from several hours to a few minutes.
- The idea is to apply pressure to the surface of the antibody-containing solution. This pressure is applied without contact using a jet of air generated either by an ultrasonic transducer or a speaker.
- Tapping the surface spontaneously induces rapid mixing of the solution, thereby increasing the chances of antibodies and antigens encountering each other.
Market
- The global IHC market is expected to reach approximately $3.7 billion by 2030, with an average annual growth rate of 8.6%. This is due to an increase in cancer cases, an ageing population and early diagnosis.
- Technological advances, such as automation and machine learning in IHC, as well as the rise of personalised medicine, are driving demand for high-performance IHC solutions.
Development
- Validated in vitro results
- Tests carried out on cancer tissue solutions
IP
- Patent application filed on December 9, 2024.
Valorisation strategy
- Licensing